Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product
Status:
Completed
Trial end date:
2021-10-10
Target enrollment:
Participant gender:
Summary
This study will investigate the bioavailability in fasting male and/or non-pregnant and non-
breast feeding female subjects of 1 capsule formulation containing Oseltamivir Phosphate 75
mg.
The study will be performed at a single site with 36 subjects. Participants will take 1
capsule of the test product and reference product in 2 periods and 2 sequences (either test
after reference or reference after test). There will be a washout of at least 2 days between
each study period.